Despite this reservation, loxiglumide (a CCK antagonist) has been shown to accelerate the GE of lipid-rich liquid meals in healthy subjects [17-19,53] as well as patients with functional dyspepsia [54] and irritable bowel syndrome [55]. This evidence concerns the gene CCK and irritable bowel syndrome.